BioCentury
ARTICLE | Company News

Bayer submits MAA for radium-223 for CRPC

December 13, 2012 2:25 AM UTC

Bayer AG (Xetra:BAYN) submitted an MAA to EMA for radium-223 dichloride (formerly Alpharadin) to treat castration-resistant prostate cancer (CRPC) in patients with bone metastases. The submission trig...